Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
HPV16
100%
Breast Cancer
99%
Tumor Antigen
79%
Autoantibodies
64%
Tumor
61%
Human Papillomavirus
59%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
55%
Point-of-care
53%
Ovarian Cancer
46%
Early Detection
42%
Triple-negative Breast Cancer
38%
Antibody Detection
36%
T Cells
35%
Protein Microarray
33%
Epitope
30%
Enzyme-linked Immunosorbent Assay (ELISA)
27%
Immune Response
26%
Multiplexed
26%
Immunogenicity
25%
Human Telomerase Reverse Transcriptase (hTERT)
24%
Vaccination
22%
Cervical Cancer
22%
Head-and-neck Cancer
22%
Cervical Cancer Screening
21%
HLA-A2
21%
Healthy Individuals
21%
Cancer Patients
20%
Janus Kinase 2 (JAK2)
20%
Carbohydrate Antigen 125 (CA125)
20%
Neoepitope
20%
Serum Antibody
19%
Cancer Immunotherapy
19%
Autoantibody Biomarker
19%
Antigen Processing
18%
Human Papillomavirus-related Oropharyngeal Cancer
18%
Early Disease
18%
Bead Array
17%
Tumor Cells
17%
In Cancer
17%
Programmed Death-ligand 1 (PD-L1)
17%
Telomerase
16%
Cancer Biomarkers
16%
Human Detection
16%
Breast Cancer Risk
16%
Simultaneous Detection
16%
HPV16 E7
16%
Potential Biomarkers
15%
Early Breast Cancer
15%
MHC-I
15%
Lateral Flow Assay
15%
Immunology and Microbiology
Human Papillomavirus Type 16
86%
Epitope
77%
Tumor Antigen
72%
Autoantibodies
71%
Antigen
70%
T Cell
58%
Peptides
56%
Wart Virus
55%
Immune Response
40%
Cytotoxic T Cell
31%
Immunotherapy
27%
Proteomics
26%
Tumor Vaccine
26%
Cytotoxic T-Cell
24%
Neck
21%
B Cell
21%
P53
21%
Cancer Immunotherapy
20%
Antigen Specificity
19%
Blood Plasma
19%
Antigen Presentation
19%
Immunogenicity
19%
ELISA
19%
Allele
19%
Antibody Blood Level
18%
Squamous Cell
17%
Antigen-Presenting Cell
17%
Protein Microarray
17%
Cancer Screening
16%
Humoral Immunity
16%
Immunoassay
15%
In Vitro
14%
Tumor Cell
14%
Reverse Transcriptase
13%
Enzyme-Linked Immunosorbent Assay
12%
Lateral Flow Assay
12%
Programmed Death-Ligand 1
11%
MHC Class I
11%
Amplicon
11%
Multiple Myeloma
11%
Cell Mutant
11%
Carcinoembryonic Antigen
11%
Bioinformatics
10%
Autoimmunity
10%
Human Leukocyte Antigen
10%
Immunology
10%
Early Antigen
10%
Severe Acute Respiratory Syndrome Coronavirus 2
9%
Dendritic Cell
8%
Epstein-Barr Virus Nuclear Antigen 1
8%
Medicine and Dentistry
Breast Cancer
81%
Diseases
32%
Biological Marker
32%
Human Papillomavirus Type 16
32%
Oropharynx Carcinoma
31%
Ovarian Cancer
27%
Neoplasm
25%
Wart Virus
24%
Malignant Neoplasm
23%
Tumor
22%
Genetics
21%
Tumor Antigen
19%
Mammography
17%
Cost Efficiency
16%
Prevalence
16%
Cervical Cancer Screening
12%
Immunotherapy
11%
Prospective Study
11%
Chemoimmunotherapy
11%
Autoantibodies
10%
Estrogen Receptor
9%
COVID-19
9%
Cancer
9%
Peptide
9%
Early Antigen
9%
Estrogen
9%
Microsphere
9%
Loop-Mediated Isothermal Amplification
8%
Disease Exacerbation
8%
T Cell
8%
Recurrent Disease
8%
Cancer Immunotherapy
7%
Granulocyte Macrophage Colony Stimulating Factor
7%
Clinical Trial
7%
Chemotherapy
7%
Immunology
7%
Tumor Vaccine
7%
Telomerase Reverse Transcriptase
7%
Messenger RNA
7%
Sentinel Lymph Node Biopsy
6%
Papillomavirus Infection
6%
Tumor Cell
6%
Antigen
6%
Triple Negative Breast Cancer
6%
CA-125
6%
Public Health
6%
Cytokine
6%
Immunoassay
6%
Breast Carcinoma
6%
Nucleic Acid
6%